CHINOOK THERAPEUTICS INC's ticker is KDNY and the CUSIP is 16961L106. A total of 1 filers reported holding CHINOOK THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $10,840,357 | +46.5% | 282,154 | -11.7% | 0.01% | +37.5% |
Q1 2023 | $7,401,194 | -21.5% | 319,706 | -11.1% | 0.01% | -20.0% |
Q4 2022 | $9,426,367 | -0.0% | 359,785 | -25.0% | 0.01% | -9.1% |
Q3 2022 | $9,428,000 | +112.6% | 479,527 | +89.1% | 0.01% | +120.0% |
Q2 2022 | $4,435,000 | +334.0% | 253,582 | +306.1% | 0.01% | +400.0% |
Q1 2022 | $1,022,000 | -51.1% | 62,447 | -51.3% | 0.00% | -50.0% |
Q4 2021 | $2,089,000 | +409.5% | 128,102 | +298.6% | 0.00% | – |
Q3 2021 | $410,000 | -27.7% | 32,136 | -10.1% | 0.00% | -100.0% |
Q4 2020 | $567,000 | – | 35,736 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SILVERARC CAPITAL MANAGEMENT, LLC | 14,158 | $12,782,000 | 5.70% |
Samsara BioCapital, LLC | 3,168,388 | $44,738,000 | 5.52% |
FRAZIER MANAGEMENT LLC | 1,100,000 | $15,532,000 | 1.43% |
Altium Capital Management LP | 416,567 | $5,882,000 | 1.36% |
Affinity Asset Advisors, LLC | 200,000 | $2,824,000 | 1.01% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 170,821 | $2,412,000 | 0.64% |
Vivo Capital, LLC | 872,151 | $12,315,000 | 0.53% |
EcoR1 Capital, LLC | 931,650 | $13,155,000 | 0.49% |
ARMISTICE CAPITAL, LLC | 1,236,000 | $17,452,000 | 0.31% |
Rubric Capital Management LP | 325,863 | $4,601,000 | 0.29% |